Introduction {#sec1}
============

In the past two decades, laparoscopic surgery has advanced significantly as a substitute for conventional laparotomy in many fields, including gastroenterological surgery, due to its minimally invasive nature. Of the types of laparoscopic surgery, laparoscopic lateral segmentectomy (LLS) has been adopted worldwide since Azagra *et al.* \[[@cit0001]\] reported the use of the procedure for benign hepatic tumors.

Following the popularization of laparoscopic surgery, research and development of natural orifice transluminal endoscopic surgery (NOTES), a surgical operation that does not create incisions in the body wall, was developed with the aim of further establishing minimally invasive operative procedures; NOTES has since been applied for cholecystectomy and appendectomy \[[@cit0002]\]. There are many issues remaining to be resolved with NOTES; however, it is expected to be a minimally invasive operative procedure in the future.

Operative procedures with a reduced number of port insertion incisions (reduced port surgery -- RPS) in order to improve esthetic outcome and minimize abdominal wall destruction have attracted much attention. Single-incision laparoscopic surgery has been developed as a novel minimally invasive surgery, and has been used primarily for cholecystectomy and appendectomy \[[@cit0003]\]. Its safety has been demonstrated and it is being applied to various surgical techniques. Reduced port surgery has been used to perform LLS; at our institution, we have performed single-port access LLS in 14 patients beginning in 2010.

Aim {#sec2}
===

Here, we report our technique and patients' postoperative course in a series of single-port access LLS performed in our department. We also examine the cosmetic outcome, safety, and utility of the procedure.

Material and methods {#sec3}
====================

Patient population and selection {#sec3.1}
--------------------------------

The medical records of 54 patients who underwent laparoscopic or open lateral segmentectomy for liver disease from February 3, 2010 to October 26, 2016 at Osaka Medical College Hospital were reviewed. All patients were fully informed of the study design according to the Ethics Committee on Clinical Investigation of Osaka Medical College Hospital (No. 1828 and 1997) and provided written informed consent.

In September 9, 2009, pure LLS for hepatocellular carcinoma was introduced at our institution. Today, tumor size less than 5 cm is the main criterion for laparoscopic hepatic resection; tumor number and tumor location are not criteria. However, patients with portal or hepatic vein involvement and invasion to adjacent organs are not considered candidates for laparoscopic hepatic resection.

In October 13, 2010, single-port access LLS (single LLS) for resection of liver metastasis from colorectal cancer was initiated at our institution. Based on preoperative computed tomography (CT) imaging, LLS was performed using single-port access laparoscopy when the distance from the umbilical part of the left branch of the portal vein to the tumor margin was 10 mm or more, conventional laparoscopy when 2--10 mm or less, and laparotomy if less than 2 mm.

From February 2010 to October 2016, single LLS for liver tumors was performed in 14 patients who provided informed consent. Conventional laparoscopic lateral segmentectomy (conventional LLS), consisting of laparoscopic hepatic resection using multiple ports for a maximum liver tumor size ≤ 5 cm, was performed in 16 patients. Open lateral segmentectomy (open LS) was performed in 11 patients from February 2010 to October 2016. These 41 patients underwent lateral segmentectomy with no other concomitant surgical (i.e., colorectal) procedures.

Preoperative workup consisted of a specified protocol, including blood examinations, abdominal ultrasound, angio-CT scan, magnetic resonance imaging, and fluorodeoxyglucose-positron emission tomography. Liver volumetry was estimated using the Synapse Vincent system (Fujifilm, Tokyo, Japan) and multidetector CT. Evaluation of hepatic function was accomplished the using indocyanine green retention rate at 15 min (ICG-R15, reference range: \< 10.0%) and the Child-Pugh classification \[[@cit0004]\] of liver dysfunction.

Surgical procedure {#sec3.2}
------------------

In this series, all procedures were performed by three experienced hepatobiliary surgeons (YI, FH, KU) during the study period. All patients received potentially curative hepatic resection with removal of gross tumor with negative macroscopic margins.

All operations were performed with the patient under general anesthesia. Briefly, the patients were placed in the "French" position, with the first operator standing between the patient's legs. The second operator (the scopist) stood on the left side of the patient. A 2.0 cm umbilical vertical incision was performed for the Alexis wound retractor (S size: Applied Medical; Rancho Santa Margarita, CA, USA) by the open laparoscopy technique. The glove-port system was produced using 5-, 5-, and 12-mm laparoscopic ports through the first, second, and fourth finger of the surgical glove, respectively ([Photo 1](#f0001){ref-type="fig"}) \[[@cit0003]\]. The gas tubing ligated on the thumb of the glove was connected directly. After the glove-port system was placed in its introducer and inserted into the abdomen, continuous carbon dioxide (CO~2~) pneumoperitoneum was induced at a pressure limit of 12 mm Hg and flow of 6 l/min to decrease the risk of gas embolism. A 5-mm flexible laparoscope (Olympus Inc., Tokyo, Japan) was used for visual inspection of the abdominal cavity. The liver was evaluated in all cases with the aid of intraoperative laparoscopic ultrasonography (Prosound α7; Hitachi Aloka Medical, Ltd., Tokyo, Japan). The round ligament of the liver was preserved, and the falciform ligament was lifted.

![The glove-port system. Three laparoscopic ports were inserted through the first, second, and fourth fingers of the surgical glove. The gas tubing ligated on the thumb of the glove was connected directly](WIITM-12-30653-g001){#f0001}

A number of techniques were perfected preoperatively and performed so that the instruments were not interfering with one another. Crossing hands and reflecting the camera facilitates internal triangulation, mainly on the camera, of the operating instruments ([Photo 2 A](#f0002){ref-type="fig"}). The proposed parenchymal transection line was along the round ligament of the liver. With the right hand of the first operator, the superficial parenchymal transection of the liver (no more than 1 cm deep in the parenchyma) was achieved using the surgical tissue management system (Thunderbeat; Olympus Inc., Tokyo, Japan) ([Photo 2 B](#f0002){ref-type="fig"}). With the left hand of the first operator, the lateral segment of the liver was retracted to the outside. Small vessels were coagulated using a soft-coagulation system or surgical tissue management system. This leaves intact arteries, veins, and bile ducts, which run to segments 2 and 3, crossing the line of division. An articulating laparoscopic stapler (Endo GIA Ultra Universal Stapler; Covidien, Tokyo, Japan) was transected at the vascular pedicles with the ideal angle of staple deployment. Finally, the hepatic vein was also sectioned using a laparoscopic stapler. The resected, undivided specimen was placed in a plastic retrieval bag and removed through the umbilical incision enlarged to 5 cm. Abdominal drainage was usually omitted.

![Crossing hands technique. **A** -- Separation of the trocars allowed full movement of the instruments. The tips of both handed forceps of the first operator were crossed in the abdominal cavity. **B** -- With the right hand of the first operator, parenchymal transection of the liver was achieved. With the left hand of the first operator, the lateral segment of the liver was retracted to the outside. By crossing the left and right surgical instruments and using the laparoscope in the center, it is possible to maintain the principle of triangulation. Furthermore, the liver transection line from the umbilicus to the root of the left hepatic vein is straight, and the cut surface also becomes sagittal](WIITM-12-30653-g002){#f0002}

Details of the surgical technique in conventional four-port laparoscopic lateral segmentectomy routinely used in our department have been described in previous reports \[[@cit0005]\]. Four (and on rare occasion five) trocars (5-, 5-, 12-, and 12-mm) were used.

In the open lateral segmentectomy group, epidural analgesia was used. The open lateral segmentectomy was performed via an epigastric middle incision. Intraoperative ultrasonography was performed routinely. The hepatic pedicle was always isolated to enable performance of the Pringle maneuver when needed. Parenchymal transection was achieved with the ultrasonic dissector and surgical tissue management system. Intraparenchymal control of the major vessels was obtained with clips or nonabsorbable sutures \[[@cit0005]--[@cit0007]\].

Preoperative factors {#sec3.3}
--------------------

Data examined included preoperative, surgical, and pathological factors. Preoperative factors investigated were age, sex, viral infection status, history of previous operations, platelet count, albumin, total bilirubin, prothrombin time (PT), Child-Pugh classification, and ICG-R15.

Surgical and pathological factors {#sec3.4}
---------------------------------

Surgical factors included surgical duration, intraoperative blood loss, and blood transfusion requirements. Pathological factors evaluated included the size of the largest tumor, number of tumors, number of hepatic resections, surgical margin status, and microscopic curative resection.

Postoperative evaluation {#sec3.5}
------------------------

The following parameters were evaluated: white blood cell (WBC) counts, C-reactive protein (CRP), aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, platelet count, albumin, total bilirubin, PT, transfusion rate, pathological margins, postoperative complications, 30-day mortality, and hospital stay.

All patients who underwent laparoscopic and open lateral segmentectomy were monitored for the assessment of pain. A visual analog scale (VAS; 0--100) and analgesic use were used for pain assessment 1, 2, 4, and 7 days after surgery.

Morbidity was graded according to Clavien's classification \[[@cit0008], [@cit0009]\]. Surgical site infections were defined according to the CDC's National Nosocomial Infection Surveillance (NNIS) system \[[@cit0010]\]. Post-hepatectomy liver failure (PHLF) was diagnosed based on the International Study Group of Liver Surgery (ISGLS) definition \[[@cit0011]\].

Patient follow-up {#sec3.6}
-----------------

Patients were closely followed until November 30, 2016. Surveillance imaging, including ultrasonography and contrast-enhanced CT, and liver function were monitored at regular intervals.

Statistical analysis {#sec3.7}
--------------------

Continuous variables are expressed as median ± standard deviation (SD). Continuous variables were compared using Student's *t*-test and the χ^2^ test. Univariate analyses of categorical variables were compared using the likelihood-ratio test, Fisher's exact test or Mann-Whitney test, as appropriate. *P* \< 0.05 was considered significant. Multivariate analyses were performed by Cox proportional hazards regression; *p* \< 0.05 was considered significant. All statistical analyses were performed using JMP version 12 (SAS Institute, Inc., Cary, NC, USA).

Results {#sec4}
=======

[Table I](#t0001){ref-type="table"} reports demographic data of the three groups. There were no significant differences in the demographic or operative characteristics between groups. The number and size of the tumors were similar between groups.

###### 

Demographic data of patients who underwent lateral segmentectomy

  ----------------------------------------------------------------------------------------------------------------
  Parameter                      Single LLS          Conventional LLS    Open LS             *P*-value\
                                                                                             Single vs. convent\
                                                                                             Single vs. open\
                                                                                             Convent vs. open
  ------------------------------ ------------------- ------------------- ------------------- ---------------------
  Number                         14                  15                  25                  

  Age \[years\]                  72 (57--82)         70 (62--78)         66 (28--82)         0.7215\
                                                                                             0.1492\
                                                                                             0.1926

  Sex (male : female)            8 : 6               9 : 6               18 : 7              1.0000\
                                                                                             0.4816\
                                                                                             0.4983

  Pathology:                                                                                 

   HCC/ICC                       8                   5                   12                  0.2723\
                                                                                             0.7411\
                                                                                             0.5115

   Metastasis/others             6                   10                  13                  

  Hepatitis viral infection      6 (42.9%)           7 (46.7%)           10 (40.0%)          1.0000\
                                                                                             1.0000\
                                                                                             0.7486

  Diabetes mellitus              5 (35.7%)           7 (46.7%)           10 (40.0%)          0.7104\
                                                                                             1.0000\
                                                                                             0.7486

  Body mass index \[kg/m^2^\]    23.2 (15.6--29.2)   21.1 (17.9--29.4)   22.6 (18.3--29.7)   0.6130\
                                                                                             0.9878\
                                                                                             0.5151

  Albumin \[g/dl\]               4.1 (2.9--4.6)      4.1 (3.0--4.7)      4.2 (3.2--4.8)      0.8081\
                                                                                             0.3816\
                                                                                             0.5426

  Total bilirubin \[mg/dl\]      0.5 (0.3--1.2)      0.5 (0.4--2.1)      0.5 (0.3--2.2)      0.4047\
                                                                                             0.4452\
                                                                                             0.8824

  Prothrombin time (%)           98 (46--136)        108 (81--122)       104 (83--146)       0.1522\
                                                                                             0.4769\
                                                                                             0.5491

  ICGR-15 (%)                    14.8 (8.7--22.9)    12.2 (4.9--28.0)    10.4 (1.0--19.4)    0.57432\
                                                                                             0.1307\
                                                                                             0.5999

  Child's grading (A/B)          14/0                12/3                25/0                0.2241\
                                                                                             1.0000\
                                                                                             0.0561

  Number of tumors               1 (1--3)            1 (1--4)            1 (1--24)           0.1470\
                                                                                             0.0676\
                                                                                             0.1075

  Size of largest tumor \[cm\]   2.7 (1.3--7.5)      2.9 (2.0--6.2)      2.9 (0.9--28.0)     0.3100\
                                                                                             0.3622\
                                                                                             0.5937

  Repeat operation (yes/no)      14/0                15/0                23/2                1.0000\
                                                                                             0.5277\
                                                                                             0.5192
  ----------------------------------------------------------------------------------------------------------------

LLS -- laparoscopic lateral segmentectomy, LS -- lateral segmentectomy, convent -- conventional, HCC -- hepatocellular carcinoma, ICC -- intrahepatic cholangiocellular carcinoma, ICGR-15 -- indocyanine green retention rate at 15 min.

[Table II](#t0002){ref-type="table"} shows surgical outcomes. In the single LLS group, the laparoscopic procedure was successfully completed for all 14 patients. Median operative time was significantly shorter in the single LLS group (123 min; range: 50--270 min) than in the other groups (*p* = 0.0005 and 0.0019, respectively). Estimated blood loss was significantly lower in the single LLS group (10 ml; range: 0--330 ml) than in the conventional LLS group (150 ml; range: 0--1450 ml) (*p* = 0.0402). During the first 7 postoperative days, the VAS score was not significantly different between groups ([Table II](#t0002){ref-type="table"}). There was also no significant difference in the use of additional analgesia between groups.

###### 

Surgical outcomes of patients who underwent lateral segmentectomy

  -----------------------------------------------------------------------------------------------------------------
  Parameter                               Single LLS      Conventional LLS   Open LS          *P*-value\
                                                                                              Single vs. convent\
                                                                                              Single vs. open\
                                                                                              Convent vs. open
  --------------------------------------- --------------- ------------------ ---------------- ---------------------
  Number                                  14              15                 25               

  Convert                                 0               2                  --               0.2323\
                                                                                              --\
                                                                                              --

  Operative time \[min\]                  123 (50--270)   233 (108--460)     225 (117--460)   **0.0005\***\
                                                                                              **0.0019\***\
                                                                                              0.4871

  Blood loss \[ml\]                       10 (0--330)     150 (0--1450)      195 (0--910)     **0.0402\***\
                                                                                              **0.0350\***\
                                                                                              0.8567

  Blood transfusion                       0               2 (13.3%)          0                0.4828\
                                                                                              --\
                                                                                              0.1346

  Surgical margin \[mm\]                  11 (2--30)      10 (1--60)         5 (0--24)        0.0883\
                                                                                              0.1801\
                                                                                              0.7084

  Curative resection, R0                  14 (100%)       15 (100%)          21 (84.0%)       1.0000\
                                                                                              0.1140\
                                                                                              0.0978

  VAS:                                                                                        

   Day 1 after operation                  33 (25--60)     50 (20--72)        50 (30--80)      0.4509\
                                                                                              0.1784\
                                                                                              0.4012

   Day 2                                  21 (0--50)      25 (0--79)         30 (0--59)       0.5219\
                                                                                              0.7055\
                                                                                              0.7622

   Day 4                                  10 (0--10)      15 (0--52)         5 (0--50)        0.4479\
                                                                                              0.5987\
                                                                                              0.7950

   Day 7                                  3 (0--6)        0 (0--5)           5 (0--50)        0.6920\
                                                                                              0.4432\
                                                                                              0.5436

  Use of additional analgesia:                                                                

   Day 1 after operation                  1 (0--2)        1 (1--2)           2 (0--3)         0.0728\
                                                                                              0.1020\
                                                                                              0.5393

   Day 2                                  0 (0--2)        1 (0--3)           1 (0--1)         0.6419\
                                                                                              0.8250\
                                                                                              0.4509

   Day 4                                  0 (0--2)        0 (0--2)           0 (0--1)         0.8417\
                                                                                              0.1898\
                                                                                              0.2186

   Day 7                                  0 (0--1)        0 (0--0)           0 (0--0)         0.0877\
                                                                                              0.0552\
                                                                                              --

  Complications:                                                                              

   Clavien-Dindo classification \> IIIA   1 (7.1%)        0 (0%)             2 (8.0%)         0.4828\
                                                                                              1.0000\
                                                                                              0.5192

   Hospital mortality                     0               0                  1 (4.0%)         --\
                                                                                              1.0000\
                                                                                              --

   Postoperative hospital stay \[days\]   9 (5--22)       9 (7--38)          10 (6--42)       0.2340\
                                                                                              0.3665\
                                                                                              0.6624
  -----------------------------------------------------------------------------------------------------------------

LLS -- laparoscopic lateral segmentectomy, LS -- lateral segmentectomy, convent -- conventional, VAS -- visual analog scale.

Postoperatively, serum total bilirubin, albumin, PT, AST, ALT, WBC count, and CRP level, especially on the peak day, were not significantly different between groups.

The single LLS group had a 7.1% complication rate (Clavien-Dindo classification \> IIIA), which was not significantly different between groups (*p* = 0.4828 and 1.0000, respectively). Overall in-hospital mortality included 1 (4.0%) patient due to postoperative hepatectomy liver failure in the open LS group (*p* = 1.0000).

Postoperative medical treatment was similar for the three groups, including intravenous electrolyte and balanced fluid solutions. Oral intake of fluid started on postoperative day 2. The median postoperative length of intravenous medicine was 5 days in all groups. The overall median postoperative length of hospital stay was 9 days (range: 5--22 days) in the single LLS group; there was no significant difference between groups (*p* = 0.2340 and 0.3665, respectively).

Discussion {#sec5}
==========

In the era of laparoscopic surgery, reduced postoperative pain, fewer adhesions, early recovery, and cosmetically acceptable results are major goals to achieve better patient care. Several studies \[[@cit0012]--[@cit0014]\] have demonstrated that less postoperative pain and early recovery were associated with reduction in either the size or number of ports.

The performance of the single-incision laparoscopic operative procedure is rapidly spreading in many fields. However, since Gaujoux *et al.* reported the use of single-incision laparoscopic hepatectomy in a series of 5 patients in 2010 \[[@cit0015]\], there have been few studies concerning single-port access LLS \[[@cit0016]\]. Therefore, we report here the features of single-port access LLS at our institution.

First, the greatest advantage is cosmetic outcome. We have performed conventional LLS using an umbilical incision plus three ports, for a total of four ports, but single LLS uses only an umbilical incision. Because the size of the umbilical incision is defined by the size of the lateral segment (3--5 cm), and there are no differences from conventional LLS, cosmetic outcomes are naturally superior in comparison with other procedures. Cosmetic results are very important, especially for young female patients.

The next issue is invasiveness of the procedure. In the present study, we found differences in operation time and intraoperative blood loss between groups. In the case of single LLS, patients had a distance of 1 cm or more between the tumor and the umbilical part of the left branch of the portal vein; thus, bias was present when selecting patients. The reasons for this are that, in comparison with conventional LLS, the major vessels and hepatic parenchyma to segments 2 and 3 are handled using the staplers; furthermore, in comparison with open LS, abdominal closure can be performed in a shorter time. However, we found no significant differences in the main factors related to invasiveness, specifically postoperative laboratory data and postoperative hospital length of stay. Postoperative pain assessment did not demonstrate superiority of the single incision technique. This may be due to the fact that in conventional LLS, the extended umbilical incision is the main cause of postoperative pain, rather than port insertion incisions other than the umbilicus.

What are the disadvantages of single-port access LLS? In single LLS, because multiple surgical instruments are inserted via one incision to approach the lesion, mutual interference of surgical instruments tends to occur. In addition, in some cases, due to interference of the forceps, sufficient traction cannot be obtained and it may be difficult to create an optimal visual field for the surgical site. However, it is our opinion that these issues can be solved by using the laparoscope in the center and crossing the left and right surgical instruments. Thus, the triangular formation made by the left and right forceps and the laparoscope can be secured. Furthermore, due to the triangular formation, the liver transection line from the umbilicus is straight, and the cut surface also becomes sagittal; as a result, operative treatment can be performed with a relatively favorable field of view.

The most important point to consider is hemorrhage control. Hemostatic control is difficult in some cases of LLS, including both the single- and multiple incision methods. However, by crossing the left and right surgical instruments to ensure a triangular formation, it is possible to perform the operation while directly viewing the liver stumps of the remnant side and the excised side. By doing so, the operation could be completed in our facility in all cases using a single port and without excessive blood loss. Regarding hemorrhage control, the single-port access method is not inferior to the conventional method.

In comparison with conventional LLS, the number of forceps used in single-port access LLS can be reduced. For this reason, there are disadvantages concerning operability of the forceps. In order to compensate for these drawbacks, the development of various devices has been actively conducted \[[@cit0017]\]. The glove-port system is one of these innovations. In this system, a single 2.0 cm umbilical incision is large enough to pass three devices through, and additional forceps can be added through the three fingers of the surgical glove without additional incisions. In this way, further improvements in laparoscopic surgery due to surgical instrument and device innovations can be expected in the future.

Conclusions {#sec6}
===========

Single-port access LLS is a procedure with excellent cosmetic results. With regard to invasiveness, there are no major differences from conventional LLS, but the use of a single incision allows the procedure to be completed with shorter operative duration and reduced intraoperative blood loss. However, because the number of patients in the present study is small and there were various biases present, the level of evidence presented here is low. Future studies, including randomized controlled trials and meta-analyses, are necessary.
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